Sansure Immunological Technology Platform adopts advanced nanoparticle technology, protein labelling and modification technology, using high quality coloured latex and colloidal gold as tracers, and has developed a series of easy-to-use, highly sensitive and rapid detection products, covering SARS-CoV-2 antigen, SARS-CoV-2/InFluA/InFluB antigen, SARS-CoV-2 neutralizing antibody and other SARS-CoV-2 immunological reagents, to meet the needs of different scenarios such as home self-test, POCT and laboratory testing.
The COVID-19 pandemic has disrupted HIV testing worldwide and threatens to reverse the progress gained over the past decades. According to WHO, the human immunodeficiency virus (HIV) has infected around 84.2 million people globally. It is estimated that roughly 40.1 million people have died from the infection. The WHO reports should make countries reflect on the importance of HIV prevention, […]
You may know that hepatitis B and C are serious viral infections that can damage the liver and lead to liver cancer. However, did you know that most people are unaware of having these conditions? The World Health Organization (WHO) estimates that only 11% of all people having HBV know of their status. For HCV, it’s estimated that just 1 in 5 people […]
With SARS-CoV-2 variants still posing a serious threat to our lives, coronavirus self-test kits can help communities worldwide. Self-testing solutions have been approved by FDA and are seen as key support to laboratory examination. However, there is a lot of misperception regarding self-testing. To shed some light on the matter, we have collected some of the most popular questions and […]
Hepatitis is a life-threatening condition that causes liver inflammation and can progress to liver cirrhosis or liver cancer if not identified and treated early. That is why the World Health Organization (WHO) took it upon itself to begin World Hepatitis Day; an annual event that celebrates and raises global awareness of all hepatitis-related illnesses. This year’s Hepatitis Day theme Bringing […]
Recent studies of severe acute hepatitis of unknown origin in previously healthy youngsters in many countries have resulted in health alerts and a race to uncover the underlying cause. Between April 5 and May 26, 2022, 650 probable cases of acute hepatitis of unknown etiology in children were reported to WHO from 33 countries in 5 WHO regions. The underlying […]